Borealis Biosciences
Boston, United States· Est.
Borealis Biosciences is a biotechnology company leveraging synthetic biology and the microbiome to develop live biotherapeutic products for metabolic and gastrointestinal diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $150M
About
Borealis Biosciences is a biotechnology company leveraging synthetic biology and the microbiome to develop live biotherapeutic products for metabolic and gastrointestinal diseases.
MicrobiomeSynthetic BiologyMetabolic
Funding History
1Total raised:$150M
Venture$150M